Adiponectin, hepatocellular dysfunction and insulin sensitivity

Clinical Endocrinology

Volumn 60, Issue 2, 2004, Pages 256-263

  López Bermejo, Abel ^a   Botas, Patricia ^b   Funahashi, Tohru ^c   Delgado, Elías ^d   Kihara, Shinji ^c   Ricart, Wifredo ^a   Fernández Real, José Manuel ^a  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b Hospital S Agustin   (Spain)

^c OSAKA UNIVERSITY   (Japan)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; LIVER ENZYME;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CAUCASIAN; CIRCULATION; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LINEAR REGRESSION ANALYSIS; LIVER CELL DAMAGE; LIVER FUNCTION TEST; MALE; MULTIPLE REGRESSION; NORMAL HUMAN; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX; SPAIN; TECHNIQUE;

ADIPONECTIN; AGE FACTORS; AGED; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FATTY LIVER; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LINEAR MODELS; LIVER; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PROTEINS; SEX FACTORS;

EID: 1042276559     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2004.01977.x     Document Type: Article

References (49)

1. Angulo, P. (2002) Nonalcoholic fatty liver disease. New England Journal of Medicine, 346, 1221-1231.
2. Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., Kuriyama, H., Nishida, M., Yamashita, S., Okubo, K., Matsubara, K., Muraguchi, M., Ohmoto, Y., Funahashi, T. & Matsuzawa, Y. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemistry and Biophysics Research Communications, 257, 79-83.
3. Barth, N., Langmann, T., Schölmerich, J., Schmitz, G. & Schäffler, A. (2002) Identification of regulatory elements in the human adipose most abundant gene transcript-1 (apM-1) promoter: role of SP1/SP3 and TNF-α as regulatory pathways. Diabetologia, 45, 1425-1433.
4. Berg, A.H., Du Combs, T.P.X., Brownlee, M. & Scherer, P.E. (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nature Medicine, 7, 947-953.
5. Bonora, E., Targher, G., Alberiche, M., Bonadonna, R.C., Saggiani, F., Zenere, M.B., Monauni, T. & Muggeo, M. (2000) Homeostasis model of assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care, 23, 57-63.
6. Botas Cervero, P., Delgado Alvarez, E., Castano Fernandez, G., Diaz De Grenu, C., Prieto Santiago, J. & Diaz Cadorniga, F.J. (2002) Prevalence of diabetes mellitus and glucose intolerance in the population aged 30-75 years in Asturias, Spain. Revista Clinica Espanola, 202, 421-429.
7. Cahill, G. (1971) The Banting Memorial Lecture. Physiology of insulin in man. Diabetes, 20, 785-799.
8. Cherrington, A. (1997) The Banting Memorial Lecture. Control of glucose uptake and release by the liver in vivo. Diabetes, 48, 1198-1214.
9. Combs, T.P., Berg, A.H., Obici, S., Scherer, P.E. & Rossetti, L. (2001) Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. Journal of Clinical Investigation, 108, 1875-1881.
10. Combs, T.P., Wagner, J.A., Berger, J., Doebber, T., Wang, W.J., Zhang, B.B., Tanen, M., Berg, A.H., O'Rahilly, S., Savage, D.B., Chatterjee, K., Weiss, S., Larson, P.J., Gottesdiener, K.M., Gertz, B.J., Charron, M.J., Scherer, P.E. & Moller, D.E. (2002) Induction of adipocyte complement-related protein of 30 kilodaltons by PPARγ agonists: a potential mechanism of insulin sensitisation. Endocrinology, 143, 998-1007.
11. Day, C. & James, O. (1998) Steatohepatitis: a tale of two 'hits'? Gastroenterology, 114, 842-845.
12. Duckworth, W., Hamel, F. & Peavy, D. (1988) Hepatic metabolism of insulin. American Journal of Medicine, 85, 71-76.
13. Fernandez-Real, J.M., Lopez-Bermejo, A., Casamitjana & Ricart, W. (2003) Novel interactions of adiponectin with the endocrine system and inflammatory parameters. Journal of Clinical Endocrinology and Metabolism, 88, 2714-2718.
14. Fruebis, J., Tsao, T.S., Javorschi, S., Ebbets-Reed, D., Erickson, M.R., Yen, F.T., Bihain, B.E. & Lodish, H.F. (2001) Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proceedings of the National Academy of Sciences of the USA, 98, 2005-2010.
15. Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., Nishida, M., Kihara, S., Sakai, N., Nakajima, T., Hasegawa, K., Muraguchi, M., Ohmoto, Y., Nakamura, T., Yamashita, S., Hanafusa, T. & Matsuzawa, Y. (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arteriosclerosis, Thrombosis and Vascular Biology, 20, 1595-1599.
16. Hotta, K., Funahashi, T., Bodkin, N.L., Ortmeyer, H.K., Arita, Y., Hansen, B.C. & Matsuzawa, Y. (2001) Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes, 50, 1126-1133.
17. Hu, E., Liang, P. & Spiegelman, B.M. (1996) AdipoQ is a novel adipose-specific gene dysregulated in obesity. Journal of Biological Chemistry, 18, 10697-10703.
18. Li, Z., Yang, S., Lin, H., Huang, J., Watkins, P., Moser, A., Desimone, C., Song, X.Y. & Diehl, A.M. (2003) Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology, 37, 343-350.
19. Lindsay, R.S., Funahashi, T., Hanson, R.L., Matsuzawa, Y., Tanaka, S., Tataranni, P.A., Knowler, W.C. & Krakoff, J. (2002) Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet, 360, 57-58.
20. Maeda, N., Takahashi, M., Funahashi, T, Kihara, S., Nishizawa, H., Kishida, K., Nagaretani, H., Matsuda, M., Komuro, R., Ouchi, N., Kuriyama, H., Hotta, K., Nakamura, T., Shimomura, I. & Matsuzawa, Y. (2001) PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes, 50, 2094-2099.
21. Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H., Matsuda, M., Nagaretani, H., Furuyama, N., Kondo, H., Takahashi, M., Arita, Y., Komuro, R., Ouchi, N., Kihara, S., Tochino, Y., Okutomi, K., Horie, M., Takeda, S., Aoyama, T., Funahashi, T. & Matsuzawa, Y. (2002) Diet-induced insulin resistance in mice lacking adiponectin. Nature Medicine, 8, 731-737.
22. Marchesini, G., Brizi, M., Morselli-Labate, A.M., Bianchi, G., Bugianesi, E., McCullough, A.J., Forlani, G. & Melchionda, N. (1999) Association of nonalcoholic fatty liver disease with insulin resistance. American Journal of Medicine, 107, 450-455.
23. Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Zoli, M. & Melchionda, N. (2001) Metformin in non-alcoholic steatohepatitis. Lancet, 358, 893-894.
24. Michael, M. (2000) Loss of insulin signalling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Molecular Cell, 6, 87-97.
25. Motoshima, H., Wu, X., Sinha, M.K., Hardy, V.E., Rosato, E.L., Barbot, D.J., Rosato, F.E. & Goldstein, B.J. (2002) Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. Journal of Clinical Endocrinology and Metabolism, 87, 5662-5667.
26. Nishizawa, H., Shimomura, I., Kishida, K., Maeda, N., Kuriyama, H., Nagaretani, H., Matsuda, M., Kondo, H., Furuyama, N., Kihara, S., Nakamura, T., Tochino, Y., Funahashi, T. & Matsuzawa, Y. (2002) Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes, 51, 2734-2741.
27. Oakes, N.D., Kennedy, C.J., Jenkins, A.B., Laybutt, D.R., Chisholm, D.J. & Kraegen, E.W. (1994) A new antidiabetic agent, BRL49653, reduces lipid availability and improves insulin action and glucoregulation in the rat. Diabetes, 43, 1203-1210.
28. Ohlson, L., Larsson, B., Bjorntorp, P., Eriksson, H., Svadsudd, K., Welin, L., Tibblin, G. & Wilhelmsen, L. (1988) Risk factors for type 2 (non-insulin dependent) diabetes mellitus: thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913. Diabetologia, 31, 798-805.
29. Ouchi, N., Kihara, S., Arita, Y, Maeda, K., Kuriyama, H., Okamoto, Y., Hotta, K., Nishida, M., Takahashi, M., Nakamura, T., Yamashita, S., Funahashi, T. & Matsuzawa, Y (1999) Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation, 100, 2473-2476.
30. Ouchi, N., Kihara, S., Arita, Y., Okamoto, Y., Maeda, K., Kuriyama, H., Hotta, K., Nishida, M., Takahashi, M., Muraguchi, M., Ohmoto, Y., Nakamura, T., Yamashita, S., Funahashi, T. & Matsuzawa, Y. (2000) Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway. Circulation, 102, 1296-1301.
31. Perry, I., Wannamethee, S. & Shaper, A. (1998) Prospective study of serum γ-glutamyltransferase and risk of NIDDM. Diabetes Care, 21, 732-737.
32. Phillips, S.A., Ciaraldi, T.P., Kong, A.P., Bandukwala, R., Aroda, V., Carter, L., Baxi, S., Mudaliar, S.R. & Henry, R.R. (2003) Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy. Diabetes, 52, 667-674.
33. Ryysy, L., Hakkinen, A.M., Goto, T., Vehkavaara, S., Westerbacka, J., Halavaara, J. & Yki-Jarvinen, H. (2000) Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes, 49, 749-758.
34. Seppälä-Lindroos, A., Vehkavaara, S., Häkkinen, A.-M., Goto, T., Westerbacka, J., Sovijärvi, A., Halavaara, J. & Yki-Järvinen, H. (2002) Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. Journal of Clinical Endocrinology and Metabolism, 87, 3023-3028.
35. Spranger, J., Kroke, A., Möhlig, M., Bergmann, M., Ristow, M., Boeing, H. & Pfeiffer, A. (2003) Adiponectin and protection against type 2 diabetes mellitus. Lancet, 361, 226-228.
36. Stefan, N., Vozarova, B., Funahashi, T., Matsuzawa, Y., Weyer, C., Lindsay, R.S., Youngren, J.F., Havel, P.J., Pratley, R.E., Bogardus, C. & Tataranni, P.A. (2002) Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes, 51, 1884-1888.
37. Tilg, H. & Diehl, A.M. (2000) Cytokines in alcoholic and nonalcoholic steatohepatitis. New England Journal of Medicine, 343, 1467-1476.
38. Tomas, E., Tsao, T.S., Saha, A.K., Murrey, H., Zhang, C., Itani, S., Lodish, H. & Ruderman, N.B. (2002) Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proceedings of the National Academy of Sciences of the USA, 99, 16309-16313.
39. Vozarova, B., Stefan, N., Lindsay, R., Saremi, A., Pratley, R., Bogardus, C. & Tataranni, P. (2002) High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes, 51, 1889-1895.
40. Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R.E. & Tataranni, P.A. (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. Journal of Clinical Endocrinology and Metabolism, 86, 1930-1935.
41. Wu, X., Motoshima, H., Mahadev, K., Stalker, T.J., Scalia, R. & Goldstein, B.J. (2003) Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes. Diabetes, 52, 1355-1363.
42. Xu, A., Wang, Y., Keshaw, H., Xu, L.Y., Lam, K.S.L. & Cooper, G.J.S. (2003) The fat-derived hormone adiponectin alleviates alcoholic and non-alcoholic fatty liver diseases in mice. Journal of Clinical Investigation, 112, 91-100.
43. Yamamoto, Y., Hirose, H., Saito, I., Tomita, M., Taniyama, M., Marsubara, K., Okazaki, Y., Ishii, T., Nishikai, K. & Saruta, T. (2002) Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clinical Science, 103, 137-142.
44. Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., Eto, K., Akanuma, Y., Froguel, P., Foufelle, F., Ferre, P., Carling, D., Kimura, S., Nagai, R., Kahn, B.B. & Kadowaki, T. (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Medicine, 8, 1288-1295.
45. Yang, W.S., Jeng, C.Y., Wu, T.J., Tanaka, S., Funahashi, T., Matsuzawa, Y., Wang, J.P., Chen, C.L., Tai, T.Y. & Chuang, L.M. (2002) Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. Diabetes Care, 25, 376-380.
46. Ye, J.M., Frangioudakis, G., Iglesias, M.A., Furler, S.M., Ellis, B., Dzamko, N., Cooney, G. & Kraegen, E.W. (2002) Prior thiazolidinedione treatment preserves insulin sensitivity in normal rats during acute fatty acid elevation: role of the liver. Endocrinology, 143, 4527-4535.
47. Yoda-Murakami, M., Taniguchi, M., Takahashi, K., Kawamata, S., Saito, K., Choi-Miura, N.-H. & Tomita, M. (2001) Change in expression of GBP28/Adiponectin in carbon tetrachloride-administered mouse liver. Biochemistry and Biophysics Research Communications, 285, 372-377.
48. Yokota, T., Oritani, K., Takahashi, I., Ishikawa, J., Matsuyama, A., Ouchi, N., Kihara, S., Funahashi, T., Tenner, A.J., Tomiyama, Y. & Matsuzawa, Y. (2000) Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood, 96, 1723-1732.
49. Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., Musi, N., Hirshman, M.F., Goodyear, L.J. & Moller, D.E. (2001) Role of AMP-activated protein kinase in mechanism of metformin action. Journal of Clinical Investigation, 108, 1167-1174.